Clinical trials
Not yet recruiting Phase 2 Ovarian Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 5 |
| 2025 | 3 |
| 2026 | 21 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 32 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fudan University | 4 |
| Sun Yat-sen University | 3 |
| Beijing Biostar Pharmaceuticals Co., Ltd. | 2 |
| Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2 |
| British Columbia Cancer Agency | 1 |
| Convalife (Shanghai) Co., Ltd. | 1 |
| Dana-Farber Cancer Institute | 1 |
| Danatlas Pharmaceuticals Co., Ltd | 1 |
| Haihua Yuan | 1 |
| Jiangsu Cancer Institute & Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ovarian Neoplasms | 32 |
| Fallopian Tube Neoplasms | 6 |
| Carcinoma, Ovarian Epithelial | 4 |
| Endometrial Neoplasms | 3 |
| Stomach Neoplasms | 2 |
| Uterine Cervical Neoplasms | 2 |
| Bile Duct Neoplasms | 1 |
| Breast Neoplasms | 1 |
| Carcinoma, Transitional Cell | 1 |
| Colorectal Neoplasms | 1 |
Trials
Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.